Evidence map›Paper›PMID 27929427›Full record

ArticleCancers2016

A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy.

Michele M Kim, Rozhin Penjweini, Nathan R Gemmell, Israel Veilleux, Aongus McCarthy, Gerald S Buller, Robert H Hadfield, Brian C Wilson, Timothy C Zhu

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Multispectral singlet oxygen luminescent dosimetry (MSOLD) for Photofrin-mediated Photodynamic Therapy.Proceedings of SPIE--the International Society for Optical Engineering
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Michele M KimDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA. mickim@sas.upenn.edu.
Rozhin PenjweiniDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA. Rozhin.Penjweini@uphs.upenn.edu.
Nathan R GemmellDepartment of Electronic and Nanoscale Engineering, University of Glasgow, Glasgow G12 8LT, UK. Nathan.Gemmell@glasgow.ac.uk.
Israel VeilleuxPrincess Margaret Cancer Centre, University of Toronto, ON M5G 1L7, Canada. israel.veilleux@uhnresearch.ca.
Aongus McCarthyInstitute of Photonics and Quantum Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK. A.McCarthy@hw.ac.uk.
Gerald S BullerInstitute of Photonics and Quantum Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK. g.s.buller@hw.ac.uk.
Robert H HadfieldDepartment of Electronic and Nanoscale Engineering, University of Glasgow, Glasgow G12 8LT, UK. Robert.Hadfield@glasgow.ac.uk.
Brian C WilsonPrincess Margaret Cancer Centre, University of Toronto, ON M5G 1L7, Canada. wilson@uhnresearch.ca.
Timothy C ZhuDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA. tzhu@mail.med.upenn.edu.
University of Pennsylvania · USHeriot-Watt University · GBUniversity of Glasgow · GBPrincess Margaret Cancer Centre · CAUniversity of Toronto · CA

Funding

TUMOR HYPOXIA, PHOTOSENSITIZER, VASCULARITY AND PDTP01CA087971 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BUSCH, THERESA M, CENGEL, KEITH A · 2001 to 2019
$24.8M
Image-guided treatment planning for pleural Photodynamic TherapyR01CA154562 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ZHU, TIMOTHY C. · 2012 to 2016
$1.6M
NCI NIH HHS P01 CA087971NCI NIH HHS R01 CA154562
6 · The paper itself

Abstract

Accurate photodynamic therapy (PDT) dosimetry is critical for the use of PDT in the treatment of malignant and nonmalignant localized diseases. A singlet oxygen explicit dosimetry (SOED) model has been developed for in vivo purposes. It involves the measurement of the key components in PDT-light fluence (rate), photosensitizer concentration, and ground-state oxygen concentration ([³

Indexed as

oxygenphotodynamic therapyPhotofrinsinglet oxygen explicit dosimetry (SOED)singlet oxygen luminescence dosimetry (SOLD)

Identifiers

PMID27929427
PMCPMC5187507
OpenAlexW2560077761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.